HRSHF(HRSHF)
HRSHF
No analyst ratings available
No analyst price targets available for HRSHF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $310.09B | $325.58B | $343.23B | $378.10B | $408.34B |
| Low | $295.79B | $313.30B | $328.88B | $362.29B | $391.26B |
| High | $320.83B | $349.39B | $361.87B | $398.64B | $430.52B |
| EBITDA Avg | $35.74B | $37.52B | $39.56B | $43.58B | $47.06B |
| Low | $34.09B | $36.11B | $37.90B | $41.75B | $45.09B |
| High | $36.98B | $40.27B | $41.71B | $45.94B | $49.62B |
| EBIT Avg | $24.35B | $25.57B | $26.95B | $29.69B | $32.07B |
| Low | $23.23B | $24.60B | $25.83B | $28.45B | $30.73B |
| High | $25.20B | $27.44B | $28.42B | $31.31B | $33.81B |
| Net Income Avg | $19.71B | $21.57B | $23.55B | $30.17B | $33.43B |
| Low | $18.63B | $20.39B | $22.27B | $28.53B | $31.61B |
| High | $21.10B | $23.09B | $25.22B | $32.30B | $35.79B |
| EPS Avg | $2.14 | $2.34 | $2.55 | $3.27 | $3.62 |
| Low | $2.02 | $2.21 | $2.41 | $3.09 | $3.43 |
| High | $2.29 | $2.50 | $2.73 | $3.50 | $3.88 |
| Analysts (Rev / EPS) | 21 / 1 | 22 / 1 | 10 / 1 | 14 / 1 | 11 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $76.53B | $75.67B |
| Low | $73.15B | $72.32B |
| High | $78.68B | $77.79B |
| EBITDA Avg | $8.82B | $8.72B |
| Low | $8.43B | $8.34B |
| High | $9.07B | $8.97B |
| EBIT Avg | $6.01B | $5.94B |
| Low | $5.74B | $5.68B |
| High | $6.18B | $6.11B |
| Net Income Avg | $5.24B | $3.78B |
| Low | $4.94B | $3.56B |
| High | $5.44B | $3.92B |
| EPS Avg | $0.56 | $0.41 |
| Low | $0.53 | $0.38 |
| High | $0.58 | $0.42 |
| Analysts (Rev / EPS) | 3 / 1 | 1 / 1 |